National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 59414 [2011-24647]
Download as PDF
<![CDATA[
59414
Federal Register / Vol. 76, No. 186 / Monday, September 26, 2011 / Notices
Dated: September 20, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2011–24651 Filed 9–23–11; 8:45 am]
National Institute on Drug Abuse;
Notice of Closed Meetings
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
jlentini on DSK4TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
Advisory Neurological Disorders and
Stroke.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Neurological
Disorders and Stroke, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: October 16–18, 2011.
Time: 7 p.m. to 11:30 a.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Alan P. Koretsky, PhD,
Scientific Director, Division of Intramural
Research, National Institute of Neurological
Disorders and Stroke, NIH, 35 Convent Drive,
Room 6A908, Bethesda, MD 20892, (301)
435–2232, koretskya@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: September 19, 2011
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–24647 Filed 9–23–11; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
17:37 Sep 23, 2011
Jkt 223001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, I/
START Review Committee.
Date: October 14, 2011.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Mark Swieter, PhD, Chief,
Extramural Activities Branch, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4235, MSC
9550, 6001 Executive Blvd., Bethesda, MD
20892–9550, 301–435–1389, ms80x@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, B/
START Review Committee.
Date: October 14, 2011.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Mark Swieter, PhD, Chief,
Extramural Activities Branch, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4235, MSC
9550, 6001 Executive Blvd., Bethesda, MD
20892–9550, 301–435–1389, ms80x@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Institutional Research Training Grants (T32).
Date: November 3, 2011.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Eliane Lazar-Wesley, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4245, MSC
PO 00000
Frm 00036
Fmt 4703
Sfmt 9990
9550, 6001 Executive Blvd., Bethesda, MD
20892–9550, 301–451–4530, el6r@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIDA–
K Conflict.
Date: November 3, 2011.
Time: 5 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Gerald L. McLaughlin,
PhD, Chief, Grants Review Branch and
Contracts Review Branch, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4238, MSC
9550, 6001 Executive Blvd., Bethesda, MD
20892–9550, 301–402–6626,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Exploring Drugs of Abuse and
Transgenerational Phenotypes (R01).
Date: November 17, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Washington, DC City
Center, 1400 M Street, NW., Washington, DC
20005.
Contact Person: Minna Liang, PhD,
Scientific Review Officer, Grants Review
Branch, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH, Room
4226, MSC 9550, 6001 Executive Blvd.,
Bethesda, MD 20892–9550, 301–435–1432,
liangm@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIDA
Cutting-Edge Basic Research Awards
(CEBRA) (R21).
Date: December 2, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Scott A. Chen, PhD,
Scientific Review Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4234, MSC
9550, 6001 Executive Blvd., Bethesda, MD
20892–9550, 301–443–9511,
chensc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: September 20, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–24660 Filed 9–23–11; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 76, Number 186 (Monday, September 26, 2011)]
[Notices]
[Page 59414]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-24647]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, National Advisory Neurological
Disorders and Stroke.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in sections 552b(c)(6), Title
5 U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Neurological Disorders and Stroke, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Institute of Neurological Disorders and Stroke.
Date: October 16-18, 2011.
Time: 7 p.m. to 11:30 a.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Alan P. Koretsky, PhD, Scientific Director,
Division of Intramural Research, National Institute of Neurological
Disorders and Stroke, NIH, 35 Convent Drive, Room 6A908, Bethesda,
MD 20892, (301) 435-2232, koretskya@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS).
Dated: September 19, 2011
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-24647 Filed 9-23-11; 8:45 am]
BILLING CODE 4140-01-P
